PRJNA528564
poor survival biomarker identified by recurrent gliomas
The goal of this study was to identify more molecular features that associated with clinical outcomes by comparing the genomic profiles of primary and recurrent gliomas and reveal potential recurrence leading factors that are significant enriched in relapse tumors.